CXCL10 blockade protects mice from cyclophosphamide-induced cystitis

Journal of Immune Based Therapies and Vaccines

Volumn 6, Issue , 2008, Pages

  Sakthivel, Senthilkumar K ^a   Singh, Udai P ^b   Singh, Shailesh ^c   Taub, Dennis D ^d   Novakovic, Kristian R ^c   Lillard Jr , James W ^c,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of Louisville School of Medicine   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE PROTEIN 10 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLADDER; CD4 LYMPHOCYTE COUNT; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; GENE OVEREXPRESSION; HELPER CELL; HUMAN; ILIAC LYMPH NODE; LYMPH NODE; MAST CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN BLOOD LEVEL; SPLEEN;

EID: 56449123339     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-6-6     Document Type: Article

References (73)

1. Hanno PM Wein AJ Interstitial cystitis J Urol 1987, 138:595-6. 2442420
2. Hanno PM Diagnosis of interstitial cystitis Urol Clin North Am 1994, 21:63-6. 8284846
3. Hanno PM Sant GR Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis Urology 2001, 57:2-6. 10.1016/S0090-4295(01)01112-8 11378041
4. Perez-Marrero R Emerson L Juma S Urodynamic studies in interstitial cystitis Urology 1987, 29:27-30. 3564230
5. Sant GR Hanno PM Interstitial cystitis: Current issues and controversies in diagnosis Urology 2001, 57:82-8. 10.1016/S0090-4295(01)01131-1 11378054
6. Parsons CL The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis Urology 2007, 69:9-16. 10.1016/j.urology.2006.03.084 17462486
7. Themann H Oberdorf E Brock N Pohl J Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna Urol Int 1987, 42:37-43. 3109094
8. Vizzard MA Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis J Comp Neurol 2000, 420:335-48. 10.1002/ (SICI)1096-9861(20000508)420:3<335::AID-CNE5>3.0.CO;2-# 10754506
9. Vizzard MA Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction Exp Neurol 2000, 161:273-84. 10.1006/exnr.1999.7254 10683293
10. Vizzard MA Boyle MM Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis Brain Res 1999, 844:174-87. 10.1016/ S0006-8993(99)01936-8 10536274
11. Yoshimura N de Groat WC Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation J Neurosci 1999, 19:4644-53. 10341262
12. Batista CK Brito GA Souza ML Leitao BT Cunha FQ Ribeiro RA A model of hemorrhagic cystitis induced with acrolein in mice Braz J Med Biol Res 2006, 39:1475-81. 17146560
13. Bjorling DE Elkahwaji JE Bushman W Janda LM Boldon K Hopkins WJ Wang Z-Y Acute acrolein-induced cystitis in mice BJU Intl 2007, 99:1523-9. 10.1111/j.1464-410X.2007.06773.x
14. Klinger MB Dattilio A Vizzard MA Expression of cyclooxygenase-2 in urinary bladder in rats with cyclophosphamide-induced cystitis Am J Physiol Regul Integr Comp Physiol 2007, 293:R677-85. 17537839
15. Andersson MC Tobin G Giglio D Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat Br J Pharmacol 2008, 153:1438-44. 10.1038/bjp.2008.6 18246091
16. Wieseler-Frank J Maier SF Watkins LR Glial activation and pathological pain Neurochem Int 2004, 45:389-95. 10.1016/j.neuint.2003.09.009 15145553
17. Marchand F Perretti M McMahon SB Role of the immune system in chronic pain Nat Rev Neurosci 2005, 6:521-32. 10.1038/nrn1700 15995723
18. Yuridullah R Corrow KA Malley SE Vizzard MA Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis Auton Neurosci 2006, 126-127:380-9. 10.1016/ j.autneu.2006.02.030
19. Bhangoo S Ren D Miller RJ Henry KJ Lineswala J Hamdouchi C Li B Monahan PE Chan DM Ripsch MS White FA Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: A mechanism for the development of chronic sensitization of peripheral nociceptors Mol Pain 2007, 3:38-57. 2228278 18076762 10.1186/ 1744-8069-3-38
20. Seow SW Rahmat JN Bay BH Lee YK Mahendran R Expression of chemokine/ cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guerin or Lactobacillus rhamnosus strain GG in the healthy murine bladder Immunology 2008, 124:419-27. 10.1111/j.1365-2567.2007.02792.x 18217952
21. Otto G Burdick M Strieter R Godaly G Chemokine response to febrile urinary tract infection Kidney Int 2005, 68:62-70. 10.1111/ j.1523-1755.2005.00381.x 15954896
22. Gillenwater JY Wein AJ Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, MD, August 28-29, 1987 J Urol 1988, 140:203-6. 3379688
23. Malley SE Vizzard MA Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis Physiol Genomics 2002, 9:5-13. 11948286
24. Fall M Johansson SL Aldenborg F Chronic interstitial cystitis: A heterogeneous syndrome J Urol 1987, 137:35-8. 3795363
25. Johansson SL Fall M Clinical features and spectrum of light microscopic changes in interstitial cystitis J Urol 1990, 143:1118-24. 2342171
26. Johansson SL Fall M Pathology of interstitial cystitis Urol Clin North Am 1994, 21:55-62. 8284845
27. Tomaszewski JE Landis JR Russack V Williams TM Wang LP Hardy C Brensinger C Matthews YL Abele ST Kusek JW Nyberg LM Interstitial Cystitis Database Study Group Biopsy features are associated with primary symptoms in interstitial cystitis: Results from the interstitial cystitis database study Urology 2001, 57:67-81. 10.1016/ S0090-4295(01)01166-9 11378053
28. Theoharides TC Panic disorder, interstitial cystitis, and mast cells J Clin Psychopharmacol 2004, 24:361-4. 10.1097/01.jcp.0000132451.50725.ee 15232325
29. Sant GR Kempuraj D Marchand JE Theoharides TC The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis Urology 2007, 69:34-40. 10.1016/j.urology.2006.08.1109 17462477
30. Nishioji K Okanoue T Itoh Y Narumi S Sakamoto M Nakamura H Morita A Kashima K Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes Clin Exp Immunol 2001, 123:271-9. 1905987 11207658 10.1046/j.1365-2249.2001.01391.x
31. Kabashima H Yoneda M Nagata K Hirofuji T Ishihara Y Yamashita M Maeda K The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas Cytokine 2001, 16:62-6. 10.1006/ cyto.2001.0947 11683586
32. Kabashima H Yoneda M Nagata K Hirofuji T Maeda K The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues Cytokine 2002, 20:70-7. 10.1006/cyto.2002.1985 12445801
33. Liu MT Keirstead HS Lane TE Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis J Immunol 2001, 167:4091-7. 11564831
34. Salmaggi A Gelati M Dufour A Corsini E Pagano S Baccalini R Ferrero E Scabini S Silei V Ciusani E De Rossi M Expression and modulation of IFN-gamma-inducible chemokines (IP-10, MIG, and I-TAC) in human brain endothelium and astrocytes: Possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis J Interferon Cytokine Res 2002, 22:631-40. 10.1089/10799900260100114 12162873
35. Belperio JA Keane MP Burdick MD Lynch JP 3rd Xue YY Li K Ross DJ Strieter RM Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome J Immunol 2002, 169:1037-49. 12097412
36. Agostini C Cassatella M Zambello R Trentin L Gasperini S Perin A Piazza F Siviero M Facco M Dziejman M Chilosi M Qin S Luster AD Semenzato G Involvement of the IP-10 chemokine in sarcoid granulomatous reactions J Immunol 1998, 161:6413-20. 9834133
37. Flier J Boorsma DM van Beek PJ Nieboer C Stoof TJ Willemze R Tensen CP Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation J Pathol 2001, 194:398-405. 10.1002/ 1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S 11523046
38. Uguccioni M Gionchetti P Robbiani DF Rizzello F Peruzzo S Campieri M Baggiolini M Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis Am J Pathol 1999, 155:331-6. 1866859 10433925
39. Singh UP Singh S Taub DD Lillard JW Jr Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10(-/-) mice J Immunol 2003, 171:1401-06. 12874231
40. Singh UP Singh S Weaver CT Iqbal N McGhee JR Lillard JW Jr IFN-γ-inducible chemokines enhance adaptive immunity and colitis J Interferon Cytokine Res 2003, 23:591-600. 10.1089/107999003322485099 14585199
41. Singh UP Singh R Singh S Karls RK Quinn FD Taub DD Lillard JW Jr CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis BMC Immunol 2008, 9:25-37. 2443107 18533024 10.1186/1471-2172-9-25
42. Singh UP Singh S Singh R Cong Y Taub DD Lillard JW Jr CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition J Interferon Cytokine Res 2008, 28:31-43. 2435497 18370870 10.1089/jir.2007.0059
43. Singh UP Venkataraman C Singh R Lillard JW Jr CXCR3 axis: Role in inflammatory bowel disease and its therapeutic implication Endocr Metab Immune Disord Drug Targets 2007, 7:111-23. 10.2174/187153007780832109 17584151
44. Christmas TJ Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis Br J Urol 1994, 73:508-15. 8012772
45. Brode S Raine T Zaccone P Cooke A Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+ Foxp3+ regulatory T cells J Immunol 2006, 177:6603-12. 17082572
46. Matsushita N Pilon-Thomas SA Martin LM Riker AI Comparative methodologies of regulatory T cell depletion in a murine melanoma model J Immunol Methods 2008, 333:167-79. 18295790
47. Brode S Cooke A Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide Crit Rev Immunol 2008, 28:109-26. 18540827
48. Schabowsky R-H Madireddi S Sharma R Yolcu ES Shirwan H Targeting CD4+ CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy Curr Opin Investig Drugs 2007, 8:1002-8. 18058571
49. Karni A Balashov K Hancock WW Bharanidharan P Abraham M Khoury SJ Weiner HL Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis J Neuroimmunol 2004, 146:189-98. 10.1016/j.jneuroim.2003.10.036 14698862
50. Sharif S Arreaza GA Zucker P Delovitch TL Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes Ann NY Acad Sci 2002, 958:77-88. 12021086
51. Sharif S Arreaza GA Zucker P Mi QS Sondhi J Naidenko OV Kronenberg M Koezuka Y Delovitch TL Gombert JM Leite-De-Moraes M Gouarin C Zhu R Hameg A Nakayama T Taniguchi M Lepault F Lehuen A Bach JF Herbelin A Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes Nature Med 2001, 7:1057-62. 10.1038/nm0901-1057 11533711
52. Gasperini S Marchi M Calzetti F Laudanna C Vicentini L Olsen H Murphy M Liao F Farber J Cassatella MA Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils J Immunol 1999, 162:4928-37. 10202039
53. Davidson NJ Leach MW Fort MM Thompson-Snipes L Kuhn R Muller W Berg DJ Rennick DM T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice J Exp Med 1996, 184:241-51. 2192682 8691138 10.1084/jem.184.1.241
54. Pizarro TT Arseneau KO Cominelli F Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease Am J Physiol Gastrointest Liver Physiol 2000, 278(5):G665-G669. 10801257
55. Dwinell MB Lugering N Eckmann L Kagnoff MF Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells Gastroenterol 2001, 120:49-59. 10.1053/gast.2001.20914
56. Sasaki S Yoneyama H Suzuki K Suriki H Aiba T Watanabe S Kawauchi Y Kawachi H Shimizu F Matsushima K Asakura H Narumi S Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival Eur J Immunol 2002, 32:3197-205. 10.1002/ 1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1 12555665
57. Suzuki K Kawauchi Y Palaniyandi SS Veeraveedu PT Fujii M Yamagiwa S Yoneyama H Han GD Kawachi H Okada Y Ajioka Y Watanabe K Hosono M Asakura H Aoyagi Y Narumi S Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells Pathol Int 2007, 57:413-20. 10.1111/j.1440-1827.2007.02117.x 17587240
58. Wenzel J Wiechert A Merkel C Bieber T Tuting T IP10/CXCL10 - CXCR3 interaction: A potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus Acta Derm Venereol 2007, 87:112-7. 10.2340/00015555-0194 17340016
59. Iijima W Ohtani H Nakayama T Sugawara Y Sato E Nagura H Yoshie O Sasano T Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: A potential self-recruiting mechanism Am J Pathol 2003, 163:261-8. 1868180 12819030
60. Frangogiannis NG Mendoza LH Smith CW Michael LH Entman ML Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia Cell Tissue Res 2000, 302:365-76. 10.1007/s004410000274 11151448
61. Gomes TN Santos CC Souza-Filho MV Cunha FQ Ribeiro RA Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis Braz J Med Biol Res 1995, 28:1103-8. 8634684
62. Peters KM Diokno AC Steinert BW Preliminary study on urinary cytokine levels in interstitial cystitis: Does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder? Urology 1999, 54:450-3. 10.1016/ S0090-4295(99)00162-4 10475352
63. Abdel-Mageed AB NF-kappa B-dependent gene expression of proinflammatory cytokines in T24 cells: Possible role in interstitial cystitis Urol Res; 2003. 14574533
64. Renzetti LM Paciorek PM Tannu SA Rinaldi NC Tocker JE Wasserman MA Gater PR Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways J Pharmacol Exp Ther 1996, 278:847-53. 8768739
65. Saban R Saban MR Nguyen NB Hammond TG Wershil BK Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice Physiol Genomics 2001, 7:35-43. 11595790
66. Theoharides TC Kempuraj D Sant GR Mast cell involvement in interstitial cystitis: A review of human and experimental evidence Urology 2001, 57:47-55. 10.1016/S0090-4295(01)01129-3 11378050
67. Batler RA Sengupta S Forrestal SG Schaeffer AJ Klumpp DJ Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha J Urol 2002, 168:819-25. 10.1016/ S0022-5347(05)64750-7 12131374
68. Romagnani S Induction of TH1 and TH2 responses: A key role for the 'natural' immune response? Immunol Today 1992, 13:379-81. 10.1016/ 0167-5699(92)90083-J 1418371
69. Harrington DS Fall M Johansson SL Interstitial cystitis: Bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis J Urol 1990, 144:868-71. 2204728
70. Bonecchi R Bianchi G Bordignon PP D'ambrosio D Lang R Borsatti A Sozzani S Allavena P Gray PA Mantovani A Sinigaglia F Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 1998, 187:129-134. 2199181 9419219 10.1084/jem.187.1.129
71. Luster AD Ravetch JV Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) J Exp Med 1987, 166:1084-97. 2188708 2443596 10.1084/jem.166.4.1084
72. Hardi R Mayer L Targan SR Yellin M Cardarelli PM Das KM A phase 1 open-label, single-dose, dose-escalation study of mdx-1100 a high-affinity, neutralizing, fully human IggIk Anti-CXCL10 (IP10) Gastroenterol 2008, 134:A99-A100.
73. Yellin M Goldwater R Blanset DL Cardarelli PM A double-blind, placebo-controlled, dose-escalation, safety and pharmacokinetic study of MDX- a fully human anti-CXCL10 monoclonal antibody, in healthy subjects Gastroenterol 1100, 134:A493-A494.